As a result of these reports of problems with Voltaren Gel, new warnings will be added to the drug to address the possibility that it cause liver damage. ...
This patent is listed in the US Food and Drug Administration's (FDA) Orange Book and expires in October 2015. With respect to Endo's regulatory approach, ...
The one trial that compared aspirin to a placebo showed no clear benefits from the drug; in contrast, a study on the NSAID indomethacin found that women ...
...Drug Administration (FDA) maakte op 12 januari 2010 melding van hepatotoxiciteit optredend gedurende de eerste maanden van het gebruik van Voltaren®. ...
